Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity

被引：0

作者：

Koos P. J. van Dam

Adriaan G. Volkers

Luuk Wieske

Eileen W. Stalman

Laura Y. L. Kummer

Zoé L. E. van Kempen

Joep Killestein

Sander W. Tas

Laura Boekel

Gerrit J. Wolbink

Anneke J. van der Kooi

Joost Raaphorst

R. Bart Takkenberg

Geert R. A. M. D’Haens

Phyllis I. Spuls

Marcel W. Bekkenk

Annelie H. Musters

Nicoline F. Post

Angela L. Bosma

Marc L. Hilhorst

Yosta Vegting

Frederike J. Bemelman

Alexandre E. Voskuyl

Bo Broens

Agner Parra Sanchez

Cécile A. C. M. van Els

Jelle de Wit

Abraham Rutgers

Karina de Leeuw

Barbara Horváth

Jan J. G. M. Verschuuren

Annabel M. Ruiter

Lotte van Ouwerkerk

Diane van der Woude

Renée C. F. Allaart

Y. K. Onno Teng

Pieter van Paassen

Matthias H. Busch

Papay B. P. Jallah

Esther Brusse

Pieter A. van Doorn

Adája E. Baars

Dirk Jan Hijnen

Corine R. G. Schreurs

W. Ludo van der Pol

H. Stephan Goedee

Maurice Steenhuis

Sofie Keijzer

Jim B. D. Keijser

Olvi Cristianawati

机构：

[1] University of Amsterdam,Department of Neurology and Neurophysiology, Amsterdam Neuroscience, Amsterdam UMC, Location AMC

[2] Amsterdam UMC,Department of Gastroenterology and Hepatology, Location Academic Medical Center

[3] University of Amsterdam,Department of Clinical Neurophysiology

[4] St Antonius Hospital,Department of Immunopathology, Sanquin Research and Landsteiner Laboratory

[5] Amsterdam UMC,Department of Neurology

[6] Amsterdam UMC,Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Department of Rheumatology and Clinical Immunology

[7] VU University Medical Center,Department of Dermatology, Amsterdam UMC, Location Academic Medical Center

[8] University of Amsterdam,Department of Internal Medicine, Section of Nephrology, Amsterdam UMC, Location Academic Medical Center

[9] Amsterdam Rheumatology and Immunology Center,Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center

[10] Location Reade,Centre for Infectious Disease Control

[11] Department of Rheumatology,Faculty of Veterinary Medicine

[12] University of Amsterdam,Department of Rheumatology and Clinical Immunology

[13] University of Amsterdam,Department of Dermatology, Center for Blistering Diseases

[14] VU University Medical Center,Department of Neurology

[15] National Institute for Public Health and the Environment (RIVM),Department of Rheumatology

[16] Utrecht University Utrecht,Centre of Expertise for Lupus

[17] University Medical Center Groningen,, Vasculitis

[18] University Medical Center Groningen, and Complement

[19] University Groningen,Mediated Systemic Diseases, Department of Internal Medicine – Nephrology section

[20] Leiden University Medical Center,Department of Nephrology and Clinical Immunology

[21] Leiden University Medical Center,Department of Neurology

[22] Leiden University Medical Centre,Department of Dermatology

[23] Maastricht University Medical Center,Department of Neurology and Neurosurgery

[24] Erasmus MC University Medical Center,Swammerdam Institute for Life Sciences

[25] Erasmus MC University Medical Center,Department of Pediatric Immunology, Rheumatology and Infectious Disease, Amsterdam UMC, Location AMC

[26] Brain Center UMC Utrecht,undefined

[27] University of Amsterdam,undefined

[28] University of Amsterdam,undefined

来源：

BMC Infectious Diseases | / 23卷

关键词：

SARS-CoV-2; Covid-19; Autoimmune disease; Immune-mediated inflammatory diseases; Immunosuppression; TNF; Immunity; Antibodies; Disease activity; Flare;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 83 条

[1]

Cromer D(2021)Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection Nat Rev Immunol 21 395-404

[2]

Juno JA(2022)Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2 N Engl J Med 386 2201-2212

[3]

Khoury D(2022)Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study The Lancet Rheumatology 4 e338-e350

[4]

Goldberg Y(2021)Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab Gut 70 865-875

[5]

Mandel M(2021)Outcomes of COVID-19 infection in multiple sclerosis and related conditions: One-year pandemic experience of the multicenter New York COVID-19 Neuroimmunology Consortium (NYCNIC) Mult Scler Relat Disord 55 880-882

[6]

Bar-On YM(2021)SARS-CoV-2 Antibodies in Adult Patients With Multiple Sclerosis in the Amsterdam MS Cohort JAMA Neurol 78 102580-1935

[7]

Wieske L(2022)DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study Semin Arthritis Rheum 55 1928-e29

[8]

van Dam KPJ(2022)SARS-CoV-2 triggering autoimmune diseases Cytokine 154 e417-3499

[9]

Steenhuis M(2021)A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center J Autoimmun 117 e77969-397

[10]

Kennedy NA(2022)Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients Rheumatology (Oxford) 61 100-1230

← 1 2 3 4 5 6 7 8 9 →